Long COVID Neurological Outcomes and Anti-Idiotype Antibodies with Prof. Dr. William Murphy

Long COVID Neurological Outcomes and Anti-Idiotype Antibodies with Prof. Dr. William Murphy Let’s review the latest paper by Dr. William Murphy about the anti-Idiotype antibodies and their role in neurological outcomes in long COVID. Brief bio of Dr. Murphy: My research for the past 30 years has centered on translational studies involving modeling cancer-immune system interactions starting with my earlier studies on NK cells and HSCT in mouse models and later at the National Cancer Institute on their role in cancer immunotherapy which then expanded to issues in immunotherapy in general. If you like this content and want more, I am doing a special lifetime membership offer. Click here: Want to support this work?: Buy me a coffee :-) Become my patron: PayPal: #drbeen #koolbeens #COVID Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.